ROCHESTER, Mich. and LONDON , June 12, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate at the ROTH London Conference being held on June 19-20, 2018 at the Dorchester

ROCHESTER, MI / ACCESSWIRE / May 21, 2018 /  OptimizeRx Corp.  (OTCQB: OPRX), the nation's leading provider of digital health messaging for the pharmaceutical industry, has been invited to present at 8th Annual LD Micro Invitational Conference being held on June 4-6, 2018 at the Luxe Sunset Bel Air

ROCHESTER, Mich. , May 14, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), one of the nation’s leading providers of digital health messaging for the pharmaceutical industry, has partnered with Patient Connect , an international provider of patient support and engagement through digital, to

ROCHESTER, Mich. , May 14, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), one of the nation’s leading providers of digital health messaging for the pharmaceutical industry, will effect a 1-for-3 reverse split of its common stock effective prior to the opening of the market today, May 14 ,

ROCHESTER, Mich. , May 09, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has been invited to participate at B. Riley FBR’s 19th Annual Institutional Investor Conference being held on May 23-24, 2018

ROCHESTER, Mich. , May 08, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has closed its private placement of common stock with two institutional investors, including The Special Situations Funds,

ROCHESTER, Mich. , May 02, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has entered into a definitive agreement with two institutional investors and a large family office for a private offering of

ROCHESTER, Mich. , May 02, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2018 . Quarterly comparisons are to the same year-ago quarter.

ROCHESTER, Mich. and NASHVILLE, Tenn. , April 23, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, has partnered with EvidenceCare, a Nashville -based provider of a cloud-based clinical decision

ROCHESTER, Mich. , April 18, 2018 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OTCQB:OPRX), the nation’s leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Wednesday, May 2, 2018 at 4:30 p.m. Eastern time to discuss results for the first quarter